Literature DB >> 29955965

Immunoreactivity patterns of tight junction proteins are useful for differential diagnosis of human salivary gland tumors.

Tomoyuki Aoyama1,2, Akira Takasawa1, Masaki Murata3, Makoto Osanai1, Kenichi Takano4, Tadashi Hasagawa2, Norimasa Sawada1.   

Abstract

The expression pattern of tight junction proteins (TJPs) varies among organs and tumor types. In this study, we examined the immunoreactivity of claudin (CLDN)-1, -4, and -7, and JAM-A in salivary gland tumors (SGTs) by histological types and cell types to estimate their usefulness as differential diagnostic markers. Immunoreactivity of CLDN1 was higher in ductal epithelium cells of SGTs than in non-tumor tissues. Conversely, immunoreactivity of CLDN1 was significantly decreased in basal/myoepithelium cells of SGTs compared with that in non-tumor tissues. There was no significant difference between the immunoreactivity of CLDN1 in benign tumors and that in malignant tumors. Immunoreactivity of CLDN4, CLDN7, and JAM-A in ductal epithelium cells was higher in many SGTs than in non-tumor tissues. There was a difference depending on the histological type of SGT in immunoreactivity of CLDN4, CLDN7, and JAM-A in basaloid/myoepithelial cells. It was possible to classify SGTs by a hierarchical clustering using immunoreactivity of TJPs. The results suggest that an immunohistochemical marker panel including these TJPs may be useful for differential diagnosis of SGTs and that CLDN1 is associated with tumorigenesis of SGTs.

Entities:  

Keywords:  Claudin-1; Claudin-4; Claudin-7; JAM-A; Salivary gland tumor; Tight junction

Mesh:

Substances:

Year:  2018        PMID: 29955965     DOI: 10.1007/s00795-018-0199-6

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  5 in total

1.  A systemic apolipoprotein A-IV-associated amyloidosis confirmed by proteome analysis.

Authors:  Taro Murakami; Akira Takasawa; Asako Moriki; Yusuke Igaki; Hiroshi Ikeda; Kazuyuki Murase; Kohichi Takada; Kazufumi Magara; Tomoyuki Aoyama; Yusuke Ono; Daisuke Kyuno; Kumi Takasawa; Masaki Murata; Makoto Osanai
Journal:  Virchows Arch       Date:  2021-03-10       Impact factor: 4.064

2.  Expression of Claudin-1 in laryngeal squamous cell carcinomas (LSCCs) and its significance.

Authors:  Abderrahman Ouban
Journal:  Histol Histopathol       Date:  2021-02-25       Impact factor: 2.303

Review 3.  The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression.

Authors:  Kamila Czubak-Prowizor; Anna Babinska; Maria Swiatkowska
Journal:  Mol Cell Biochem       Date:  2021-09-17       Impact factor: 3.396

4.  Claudin-7 Inhibits Proliferation and Metastasis in Salivary Adenoid Cystic Carcinoma Through Wnt/β-Catenin Signaling.

Authors:  Huan Ji; Xu Ding; Wei Zhang; Yang Zheng; Hongming Du; Yangyu Zheng; Haiyang Song; Meng Li; Yue Jiang; Jiaxiang Xie; Ming Wu; Pengfei Jiao; Zeyu Wang; Heming Wu; Yi Zhong
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

5.  Aberrant expression of claudin-6 contributes to malignant potentials and drug resistance of cervical adenocarcinoma.

Authors:  Yui Ito; Akira Takasawa; Kumi Takasawa; Taro Murakami; Taishi Akimoto; Daisuke Kyuno; Yuka Kawata; Kodai Shano; Kurara Kirisawa; Misaki Ota; Tomoyuki Aoyama; Masaki Murata; Kotaro Sugimoto; Hideki Chiba; Tsuyoshi Saito; Makoto Osanai
Journal:  Cancer Sci       Date:  2022-02-13       Impact factor: 6.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.